Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Pearson says enters 2026 with ′momentum′ after sales grow in 2025 (Alliance) +++ PEARSON Aktie -4,63%

NOVAVAX Aktie

 >NOVAVAX Aktienkurs 
7.283 EUR    -2.4%    (Tradegate)
Ask: 7.345 EUR / 1500 Stück
Bid: 7.285 EUR / 1500 Stück
Tagesumsatz: 18760 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
NOVAVAX Aktie über LYNX handeln
>NOVAVAX Performance
1 Woche: +19,0%
1 Monat: +33,5%
3 Monate: -0,6%
6 Monate: +27,9%
1 Jahr: -10,7%
laufendes Jahr: +29,6%
>NOVAVAX Aktie
Name:  NOVAVAX INC. DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US6700024010 / A2PKMZ
Symbol/ Ticker:  NVV1 (Frankfurt)
Kürzel:  FRA:NVV1, ETR:NVV1, NVV1:GR
Index:  -
Webseite:  https://novavax.com/
Profil:  Novavax Inc. is a biotechnology company specializi..
>Volltext..
Marktkapitalisierung:  1081.43 Mio. EUR
Unternehmenswert:  635.36 Mio. EUR
Umsatz:  914.23 Mio. EUR
EBITDA:  387.91 Mio. EUR
Nettogewinn:  293.46 Mio. EUR
Gewinn je Aktie:  1.83 EUR
Schulden:  215.66 Mio. EUR
Liquide Mittel:  239.44 Mio. EUR
Operativer Cashflow:  -324.87 Mio. EUR
Bargeldquote:  1.8
Umsatzwachstum:  14.12%
Gewinnwachstum:  -
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  NOVAVAX
Letzte Datenerhebung:  14.01.26
>NOVAVAX Kennzahlen
Aktien/ Unternehmen:
Aktien: 162.5 Mio. St.
Frei handelbar: 95.26%
Leerverk. Aktien: -
Rückkaufquote: 0.41%
Mitarbeiter: 952
Umsatz/Mitarb.: 0.62 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 46.27%
Bewertung:
KGV: 4.95
KGV lG: 4.12
KUV: 1.12
KBV: -
PEG-Ratio: -
EV/EBITDA: 1.64
Rentabilität:
Bruttomarge: 90.6%
Gewinnmarge: 32.1%
Operative Marge: 39.14%
Managementeffizenz:
Gesamtkaprendite: 23.63%
Eigenkaprendite: -
>NOVAVAX Peer Group

Es sind 592 Aktien bekannt.
 
13.01.26 - 21:36
CORRECTED: Why Is Novavax Stock Soaring? (Benzinga)
 
Novavax Inc (NASDAQ:NVAX) shares are trading higher. Reports show a rise in respiratory illnesses across the United States. read more...
13.01.26 - 16:45
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
 
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects....
07.01.26 - 14:03
Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
 
GAITHERSBURG, Md., Jan. 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the 44th Annual J.P. Morgan Healthcare Conference. Conference Details: Presentation Date: Wednesday, January 14, 2026 Time: 4:30 p.m. Pacific Time Location: San......
06.01.26 - 01:00
Novavax (NVAX) Outpaces Stock Market Gains: What You Should Know (Zacks)
 
In the most recent trading session, Novavax (NVAX) closed at $7.25, indicating a +1.68% shift from the previous trading day....
30.12.25 - 16:45
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
 
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store....
19.12.25 - 17:00
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know (Zacks)
 
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects....
11.12.25 - 19:12
Why I Wouldn′t Touch Novavax With a 10-Foot Pole (Fool)
 
This stock could be a wealth destroyer in the next five years....
08.12.25 - 16:45
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock (Zacks)
 
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock....
01.12.25 - 19:39
Vaccine Stocks Drop After FDA Memo Links COVID Shots To Child Deaths (ZeroHedge)
 
Vaccine Stocks Drop After FDA Memo Links COVID Shots To Child Deaths Vaccine stocks slumped Monday after an explosive memo from FDA vaccine chief Vinay Prasad surfaced late Friday, signaling the agency is preparing to roll out tough restrictions on new vaccines for children. Prasad described a "profound revelation" linking Covid shots to at least ten deaths in children.  By late morning, Vaccine makers dropped on the memo: Moderna -6%, BioNTech -4.3%, Novavax -4%, Vaxcyte -6.6%. "This is a profound revelation," Prasad wrote in the memo. "For the first time, the US FDA will acknowledge that COVID-19 vaccines have killed American children." He added, "It is horrifying to consider that the US vaccine regulation, including our actions, may have harmed more children than we saved. This requires humility and introspection." Wall Street analysts weighed in on the memo, and all agreed it introduces a new regulatory overhang for vaccine stocks. Here's what...
21.11.25 - 22:09
Novavax rises after a seven-day slide (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
19.11.25 - 19:48
Novavax bei Jefferies London: Strategischer Wandel hin zu Partnerschaften (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
13.11.25 - 16:12
Shah Capital pushes for Novavax sale, warns of proxy fight (Reuters EN)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
11.11.25 - 16:45
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know (Zacks)
 
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store....
07.11.25 - 19:00
Novavax Q3 Earnings & Revenues Beat Estimates, ′25 Sales View Raised (Zacks)
 
NVAX exceeds third-quarter expectations, boosted by a Sanofi milestone payment. It lifts its 2025 sales outlook....
06.11.25 - 21:33
Novavax outlines $1.04B–$1.06B 2025 revenue framework and targets non-GAAP profitability as early as 2028 amid partnership-driven transition (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
06.11.25 - 14:42
Earnings Snapshot: Novavax tops Q3 estimates; raises FY revenue outlook (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
06.11.25 - 14:36
Novavax beats revenue estimates, raises full-year guidance (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
06.11.25 - 14:12
Novavax raises annual revenue forecast on strength of vaccine deals (Reuters EN)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
06.11.25 - 14:12
Novavax GAAP EPS of -$1.25 misses by $0.33, revenue of $70.45M beats by $25.58M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.25 - 21:00
An Overview of Novavax′s Earnings (Benzinga)
 
read more...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Man muß seine Feinde kennen. Ihre Verbündeten und die Natur ihres Landes, um einen Feldzug planen zu können. - König Friedrich II.
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!